Rita Jain
Board Member
SAB Biotherapeutics, Inc. (SABS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rita Jain
Rita Jain is recorded as Board Member at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed January 7, 2026 that Rita Jain was appointed Class II director, effective January 5, 2026.
“On January 5, 2026, the Board of Directors (the "Board") of SAB Biotherapeutics, Inc., a Delaware corporation (the "Company"), following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed, David Zaccardelli, Pharm.D, and Rita Jain, M.D. each to serve as a Class II director of the Company, effective January 5, 2026, and to serve until the Company's 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at SAB Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Samuel J. Reich CEO, Board Member
- David Zaccardelli Chairman, Board Member
- Lucy To CFO
- Mark Conley CFO
- Michael King CFO
- Christoph Bausch COO
- Andrew D. Moin Board Member
- Andrew Moin Board Member
- David Link Board Member
- Dr. Jay S. Skyler Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.